BE641880A - - Google Patents

Info

Publication number
BE641880A
BE641880A BE641880A BE641880A BE641880A BE 641880 A BE641880 A BE 641880A BE 641880 A BE641880 A BE 641880A BE 641880 A BE641880 A BE 641880A BE 641880 A BE641880 A BE 641880A
Authority
BE
Belgium
Application number
BE641880A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE641880A publication Critical patent/BE641880A/xx

Links

BE641880A 1962-12-27 1963-12-27 BE641880A (esLanguage)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP5790262 1962-12-27
JP6427663 1963-10-29
JP5741963 1963-10-29
JP6250163 1963-11-22

Publications (1)

Publication Number Publication Date
BE641880A true BE641880A (esLanguage) 1964-04-16

Family

ID=27463499

Family Applications (1)

Application Number Title Priority Date Filing Date
BE641880A BE641880A (esLanguage) 1962-12-27 1963-12-27

Country Status (5)

Country Link
BE (1) BE641880A (esLanguage)
FR (1) FR3150M (esLanguage)
GB (1) GB1080599A (esLanguage)
LU (1) LU45106A1 (esLanguage)
NL (1) NL302572A (esLanguage)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107540413A (zh) * 2017-09-14 2018-01-05 精晶药业股份有限公司 一种从门冬氨酸鸟氨酸结晶母液中提取尿素的方法

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2495608A1 (fr) * 1980-12-04 1982-06-11 Morelle Jean Nouveaux derives de l'acide aspartique et leurs usages
SG158073A1 (en) 2004-11-26 2010-01-29 Ucl Business Plc Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy
LT2413924T (lt) 2009-04-03 2018-02-12 Ocera Therapeutics, Inc. L-ornitino fenilo acetatas ir jo gavimo būdai
MX375116B (es) 2009-06-08 2025-03-06 Ucl Business Plc Tratamiento de hipertension portal y restauracion de la funcion hepatica usando fenilacetato de l-ornitina.
MX360062B (es) 2010-10-06 2018-10-22 Ocera Therapeutics Inc Metodos de elaboracion de fenilacetato de l-ornitina.
CA2968544A1 (en) 2014-11-24 2016-06-02 Ucl Business Plc Treatment of diseases associated with hepatic stellate cell activation using ammonia-lowering therapies
US10835506B2 (en) 2015-08-18 2020-11-17 Ocera Therapeutics, Inc. Treatment and prevention of muscle loss using L-ornithine in combination with at least one of phenylacetate and phenylbutyrate
AU2018266357B2 (en) 2017-05-11 2022-12-08 Ocera Therapeutics, Inc. Processes of making L-ornithine phenylacetate

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107540413A (zh) * 2017-09-14 2018-01-05 精晶药业股份有限公司 一种从门冬氨酸鸟氨酸结晶母液中提取尿素的方法

Also Published As

Publication number Publication date
LU45106A1 (esLanguage) 1964-02-24
NL302572A (esLanguage)
FR3150M (fr) 1965-02-22
GB1080599A (en) 1967-08-23

Similar Documents

Publication Publication Date Title
BE627212A (esLanguage)
BE629571A (esLanguage)
BE622995A (esLanguage)
BE624894A (esLanguage)
BE625012A (esLanguage)
BE625746A (esLanguage)
BE626513A (esLanguage)
BE626810A (esLanguage)
BE626959A (esLanguage)
BE627236A (esLanguage)
BE627263A (esLanguage)
BE627284A (esLanguage)
BE627294A (esLanguage)
BE627474A (esLanguage)
BE627516A (esLanguage)
BE627569A (esLanguage)
BE627679A (esLanguage)
BE627742A (esLanguage)
BE627899A (esLanguage)
BE627993A (esLanguage)
BE628015A (esLanguage)
BE628098A (esLanguage)
BE628331A (esLanguage)
BE628401A (esLanguage)
BE628617A (esLanguage)